[go: up one dir, main page]

NO993709D0 - Stabilisert blanding omfattende fibrinogen - Google Patents

Stabilisert blanding omfattende fibrinogen

Info

Publication number
NO993709D0
NO993709D0 NO993709A NO993709A NO993709D0 NO 993709 D0 NO993709 D0 NO 993709D0 NO 993709 A NO993709 A NO 993709A NO 993709 A NO993709 A NO 993709A NO 993709 D0 NO993709 D0 NO 993709D0
Authority
NO
Norway
Prior art keywords
fibrinogen
solution
arginine
lysine
stabilized composition
Prior art date
Application number
NO993709A
Other languages
English (en)
Other versions
NO993709L (no
Inventor
Israel Nur
Lilliana Bar
Oded Lieberman
Original Assignee
Omrix Biopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97101569A external-priority patent/EP0856317A1/en
Application filed by Omrix Biopharm Sa filed Critical Omrix Biopharm Sa
Publication of NO993709D0 publication Critical patent/NO993709D0/no
Publication of NO993709L publication Critical patent/NO993709L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO993709A 1997-01-31 1999-07-30 Stabilisert blanding omfattende fibrinogen NO993709L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97101569A EP0856317A1 (en) 1997-01-31 1997-01-31 A stabilized mixture comprising fibrinogen
PCT/EP1998/000502 WO1998033533A1 (en) 1997-01-31 1998-01-30 A stabilized mixture comprising fibrinogen

Publications (2)

Publication Number Publication Date
NO993709D0 true NO993709D0 (no) 1999-07-30
NO993709L NO993709L (no) 1999-09-28

Family

ID=8226433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993709A NO993709L (no) 1997-01-31 1999-07-30 Stabilisert blanding omfattende fibrinogen

Country Status (13)

Country Link
US (1) US6121232A (no)
JP (1) JP3825055B2 (no)
KR (1) KR100345570B1 (no)
CN (1) CN1182879C (no)
AT (1) ATE218365T1 (no)
AU (1) AU724715B2 (no)
BR (1) BR9807043A (no)
CA (1) CA2279419A1 (no)
DE (1) DE69805772T2 (no)
ES (1) ES2178153T3 (no)
HU (1) HUP0000908A3 (no)
NO (1) NO993709L (no)
PL (1) PL194316B1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
CN100345591C (zh) * 2003-08-01 2007-10-31 上海新兴医药股份有限公司 耐干热处理的速溶冻干纤维蛋白原制剂
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
EP1809343B1 (en) * 2004-10-20 2012-08-15 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101678086B (zh) * 2007-03-22 2013-07-10 财团法人化学及血清疗法研究所 固体纤维蛋白原制剂
EP2011524A1 (en) 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrin glue with a visualization agent
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
ES2438491T3 (es) * 2008-09-22 2014-01-17 Omrix Biopharmaceuticals Ltd. Dispositivo implantable que comprende un sustrato pre-recubierto con fibrina estabilizada
JP5805542B2 (ja) 2009-02-20 2015-11-04 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． 少なくとも２成分の薬物を投与する装置
CA2787883C (en) 2010-01-28 2019-02-19 Erez Ilan Method for improved fibrin sealing
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
EP2616550B1 (en) * 2010-09-15 2016-02-10 Debiopharm International SA Method for separating target molecules or particles from fibrinogen-containing samples including blood components
WO2012040595A2 (en) 2010-09-23 2012-03-29 Inflammagen Administration of serine protease inhibitors to the stomach
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
IL213375A0 (en) 2011-06-05 2011-07-31 Omrix Biopharmaceuticals Device for spraying fluids in proximity to a surface
WO2013151725A1 (en) 2012-04-05 2013-10-10 The Regents Of The University Of California Regenerative sera cells and mesenchymal stem cells
US10130346B2 (en) 2012-07-24 2018-11-20 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a bodily organ
EP2934603A1 (en) 2012-12-20 2015-10-28 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
CN105007829B (zh) 2012-12-30 2018-06-01 奥姆里克斯生物药品有限公司 用于将可固化流体组合物施用到身体器官的一部分的装置和方法
USD754325S1 (en) 2013-06-06 2016-04-19 Omrix Biopharmaceuticals Ltd. Device of a curable fluid composition to a bodily organ
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
CN112641771B (zh) 2014-03-25 2022-04-15 恒翼生物医药科技(上海)有限公司 用于治疗自身消化的组合物
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
IL234246A0 (en) 2014-08-21 2014-11-30 Omrix Biopharmaceuticals Ltd Stabilized thrombin
BR112017010250A2 (pt) 2014-11-18 2018-01-02 Omrix Biopharmaceuticals Ltd aparelho para secagem por aspersão e método de uso do mesmo
IL235751A0 (en) 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
EP3262409B1 (en) 2015-02-25 2020-03-25 Omrix Biopharmaceuticals Ltd. Method for purifying and quantifying thrombin and its degradation polypeptides
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
IL242924A0 (en) 2015-12-03 2016-04-21 Omrix Biopharmaceuticals Ltd Syringe system for storing and mixing two ingredients
US11202768B2 (en) 2016-01-11 2021-12-21 Leading BioSciences, Inc. Compositions and methods for treating and preventing adhesions and ileus
JP2017176713A (ja) * 2016-03-31 2017-10-05 テルモ株式会社 塗布具
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
CN109081789B (zh) * 2017-06-13 2021-01-01 首都医科大学 氨基正己酰氨基甲环酰氨基正己酰脂肪氨基酸，其合成，活性和应用
IL261190A (en) 2018-08-16 2019-01-31 Omrix Biopharmaceuticals Ltd Stable liquid preparations of thrombin
IL263679A (en) 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and compositions for preventing tissue adhesion
WO2020121290A1 (en) 2018-12-12 2020-06-18 Omrix Biopharmaceuticals Ltd. High concentrated protein compositions for preventing tissue adhesion
WO2023042146A1 (en) 2021-09-16 2023-03-23 Ethicon, Inc. Kit for composition for tissue tract sealing
WO2023119277A1 (en) 2021-12-21 2023-06-29 Omrix Biopharmaceuticals Ltd. Highly soluble fibrinogen compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US5278189A (en) * 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
EP0691858B1 (en) * 1993-03-30 1999-12-15 Omrix Biopharmaceuticals S.A. Two component fibrin glue

Also Published As

Publication number Publication date
PL334547A1 (en) 2000-03-13
BR9807043A (pt) 2000-03-28
DE69805772T2 (de) 2003-01-30
CN1182879C (zh) 2005-01-05
ATE218365T1 (de) 2002-06-15
ES2178153T3 (es) 2002-12-16
HUP0000908A3 (en) 2001-05-28
AU6214598A (en) 1998-08-25
US6121232A (en) 2000-09-19
CA2279419A1 (en) 1998-08-06
CN1246069A (zh) 2000-03-01
AU724715B2 (en) 2000-09-28
KR20000070634A (ko) 2000-11-25
NO993709L (no) 1999-09-28
KR100345570B1 (ko) 2002-07-26
DE69805772D1 (de) 2002-07-11
JP2000509630A (ja) 2000-08-02
HUP0000908A2 (hu) 2000-08-28
JP3825055B2 (ja) 2006-09-20
PL194316B1 (pl) 2007-05-31

Similar Documents

Publication Publication Date Title
NO993709D0 (no) Stabilisert blanding omfattende fibrinogen
ATE111360T1 (de) Chirurgisches klebstoffmaterial.
DE69230670D1 (de) Zusammensetzungen, die eine blutgerinnselpolymermatrix zur verabreichung von osteogenen proteinen enthalten
TR199800046A2 (xx) Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ES2183133T3 (es) Composiciones de lipidos.
ATE153648T1 (de) Verwendungen von alpha-hydroxyfettsäuren
ES2042693T5 (es) Formulaciones de proteinas plasmaticas y recombinantes en medios de baja potencia ionica.
EA200300065A1 (ru) Окисленные сложные эфиры 4-йодфениламинобензгидроксамовых кислот
ES2130428T3 (es) Cristales de insulina asp-b28.
FI964682A (fi) Glukagonia sisältävä farmaseuttinen valmiste
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
ES2053676T3 (es) Formulacion de proteinas plasmaticas y recombinantes en medios de fuerza ionica elevada.
ATE99943T1 (de) Psychotropische wirkstoffe enthaltende stabilisierte loesungen.
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
ES2139740T3 (es) Cola de fibrina de dos componentes.
EP1304123A3 (en) Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
AU569896B2 (en) Process for the dissolution of peptides and proteins
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
ATE305612T1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität
AR004224A1 (es) Procedimiento para la inactivacion de virus en soluciones de proteinas
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
DE69010518D1 (de) Wässerige Desmopressin-CMC enthaltende Arzneizubereitung.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application